• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺纤维化的综合征遗传病因。

Syndromic genetic causes of pulmonary fibrosis.

机构信息

Service de Pneumologie A Hôpital Bichat, APHP, Paris, France, Université Paris Cité, Inserm, PHERE, Université Paris Cité.

Laboratoire de Génétique, Hôpital Bichat.

出版信息

Curr Opin Pulm Med. 2024 Sep 1;30(5):473-483. doi: 10.1097/MCP.0000000000001088. Epub 2024 Jun 19.

DOI:10.1097/MCP.0000000000001088
PMID:38896087
Abstract

PURPOSE OF REVIEW

The identification of extra-pulmonary symptoms plays a crucial role in diagnosing interstitial lung disease (ILD). These symptoms not only indicate autoimmune diseases but also hint at potential genetic disorders, suggesting a potential overlap between genetic and autoimmune origins.

RECENT FINDINGS

Genetic factors contributing to ILD are predominantly associated with telomere (TRG) and surfactant-related genes. While surfactant-related gene mutations typically manifest with pulmonary involvement alone, TRG mutations were initially linked to syndromic forms of pulmonary fibrosis, known as telomeropathies, which may involve hematological and hepatic manifestations with variable penetrance. Recognizing extra-pulmonary signs indicative of telomeropathy should prompt the analysis of TRG mutations, the most common genetic cause of familial pulmonary fibrosis. Additionally, various genetic diseases causing ILD, such as alveolar proteinosis, alveolar hemorrhage, or unclassifiable pulmonary fibrosis, often present as part of syndromes that include hepatic, hematological, or skin disorders.

SUMMARY

This review explores the main genetic conditions identified over the past two decades.

摘要

综述目的

肺外症状的识别对间质性肺疾病(ILD)的诊断起着至关重要的作用。这些症状不仅表明自身免疫性疾病,还提示潜在的遗传疾病,表明遗传和自身免疫起源之间存在潜在的重叠。

最近的发现

与 ILD 相关的遗传因素主要与端粒(TRG)和表面活性剂相关基因有关。虽然表面活性剂相关基因的突变通常仅表现为肺部受累,但 TRG 突变最初与称为端粒体病的综合征性肺纤维化形式有关,其可能具有不同外显率的血液学和肝脏表现。识别提示端粒体病的肺外征象应促使分析 TRG 突变,这是家族性肺纤维化最常见的遗传原因。此外,导致间质性肺病的各种遗传疾病,如肺泡蛋白沉积症、肺泡出血或无法分类的肺纤维化,通常作为包括肝脏、血液或皮肤疾病在内的综合征的一部分出现。

摘要

本综述探讨了过去二十年中确定的主要遗传疾病。

相似文献

1
Syndromic genetic causes of pulmonary fibrosis.肺纤维化的综合征遗传病因。
Curr Opin Pulm Med. 2024 Sep 1;30(5):473-483. doi: 10.1097/MCP.0000000000001088. Epub 2024 Jun 19.
2
Impact of genetic factors on fibrosing interstitial lung diseases. Incidence and clinical presentation in adults.遗传因素对纤维化间质性肺疾病的影响。成人中的发病率及临床表现。
Presse Med. 2020 Jun;49(2):104024. doi: 10.1016/j.lpm.2020.104024. Epub 2020 May 11.
3
[Telomeres and lung].[端粒与肺]
Rev Mal Respir. 2022 Sep;39(7):595-606. doi: 10.1016/j.rmr.2022.03.011. Epub 2022 Jun 14.
4
Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.将基因组学纳入特发性肺纤维化的管理中。
Chest. 2019 May;155(5):1026-1040. doi: 10.1016/j.chest.2018.12.011. Epub 2019 Jan 17.
5
Inherited interstitial lung disease.遗传性间质性肺疾病。
Clin Chest Med. 2004 Sep;25(3):421-33, v. doi: 10.1016/j.ccm.2004.05.001.
6
Pulmonary fibrosis in non-mutation carriers of families with short telomere syndrome gene mutations.家族性短端粒综合征基因突变非携带者的肺纤维化。
Respirology. 2021 Dec;26(12):1160-1170. doi: 10.1111/resp.14145. Epub 2021 Sep 27.
7
Regulator of telomere length 1 () mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes.端粒长度调节因子 1()突变与异质性的肺内和肺外表型相关。
Eur Respir J. 2019 Feb 7;53(2). doi: 10.1183/13993003.00508-2018. Print 2019 Feb.
8
Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis.类风湿关节炎-间质性肺疾病和家族性肺纤维化的共享遗传易感性。
Eur Respir J. 2017 May 11;49(5). doi: 10.1183/13993003.02314-2016. Print 2017 May.
9
Genetic Testing Goes Beyond Imaging and Histological Evaluation in Pleuroparenchymal Fibroelastosis.在胸膜肺弹力纤维增生症中,基因检测优于影像学和组织学评估。
Lung. 2024 Apr;202(2):151-156. doi: 10.1007/s00408-024-00685-3. Epub 2024 Mar 10.
10
Management of suspected monogenic lung fibrosis in a specialised centre.在专科中心对疑似单基因性肺纤维化的管理。
Eur Respir Rev. 2017 Apr 26;26(144). doi: 10.1183/16000617.0122-2016. Print 2017 Jun 30.

引用本文的文献

1
An FGF2-Derived Short Peptide Attenuates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting Collagen Deposition and Epithelial-Mesenchymal Transition via the FGFR/MAPK Signaling Pathway.一种源自FGF2的短肽通过FGFR/MAPK信号通路抑制胶原蛋白沉积和上皮-间质转化,减轻博来霉素诱导的肺纤维化。
Int J Mol Sci. 2025 Jan 9;26(2):517. doi: 10.3390/ijms26020517.